Parameters studied | Patient in remission (n = 198) | p value | |
Age groups (years) | (16 - 40) | 129 (65.2%) | 0.63 |
≥40 | 69 (34.8%) | ||
Sex | Female | 165 (83.4%) | 0.90 |
Male | 33 (16.6%) | ||
Stage of goiter | Stage 0 - 1 | 65 (32.8%) | 0.007* |
Stage 2 - 3 | 134 (67.2%) | ||
Exophthalmos | yes | 127 (64.2%) | 0.10 |
No | 71 (35.8%) | ||
SAT starting dose (mg/l) | <40 | 85 (42.9%) | 0.22 |
≥40 | 113 (57%) | ||
Initial free T4 Value (pmol/l) | <50 | 89 (45%) | 0.003* |
≥50 | 109 (55%) |